Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Learn practical ways to quickly enhance your paycheck. These tips can help you maximize your earnings in no time.
21,903 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
The allure of a $16 billion contracted revenue pipeline can blind investors to real dangers. This article breaks down...
On Tuesday, a leading critical metals stock surged on news before cooling later in the day. This piece explores what ...
As the EV race heats up in 2026, investors are weighing which rivals to buy. This guide breaks down the top contender...
First Advantage stock is climbing today as investors react to better-than-expected results and a growing AI-focused d...
A pre-retiree left for a rival firm and forfeited $74,000 in 401(K) employer matching by missing the vesting cliff. T...
When Cerebras surged 68% on its first trading day, investors sat up and took notice. This piece breaks down what that...
Even the world's richest people sometimes choose debt over cash when buying luxury homes. This piece examines why bil...
Investors and households are bracing for the Federal Reserve's policy decision, with potential moves on borrowing cos...
A new alliance led by the linux foundation and tech giants forms Akrites, a security backbone for open-source project...
The EU is gearing up for a major MiCA update in 2027 to cover non‑EU stablecoin issuers and tokenized payments. This ...
Transocean (Rig) 2025 earnings could hinge on fleet utilization and day rates. This guide unpackages the drivers, ris...